Article info

Original research
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism

Authors

  1. Correspondence to Dr Nicholas Keen; nicholas.keen{at}bicycletx.com
View Full Text

Citation

Hurov K, Lahdenranta J, Upadhyaya P, et al
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism

Publication history

  • Accepted October 1, 2021
  • First published November 1, 2021.
Online issue publication 
November 01, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.